AAFP Advocates for Planned Vaginal Birth After Cesarean

Share this content:
AAFP Advocates for Planned Vaginal Birth After Cesarean
AAFP Advocates for Planned Vaginal Birth After Cesarean

(HealthDay News) -- A planned labor and vaginal birth after cesarean (LAC/VBAC) is an appropriate option for most women with a history of prior cesarean birth, according to a clinical practice guideline published in the January/February issue of the Annals of Family Medicine.

Valerie J. King, M.D., M.P.H., from the Oregon Health & Science University in Portland, and colleagues developed evidence-based guidelines to facilitate planning for LAC/VBAC. The guidelines were developed by a multidisciplinary group which used a high quality systematic review as the primary evidence source.

The authors note that clinicians should counsel, encourage, and facilitate planned VBAC, including offering referral to a facility or clinician that can offer the service if not available locally. Clinicians should inform women who have had a previous vaginal birth that they have a high likelihood of VBAC; these women should be encouraged to plan LAC/VBAC unless there are specific contraindications to vaginal birth. For women who have a medical indication for induction of labor and who are planning a LAC/VBAC, induction of labor after cesarean is appropriate. For women with a prior cesarean birth, misoprostol should not be used for cervical preparation or induction of labor after cesarean in the third trimester of pregnancy.

"The AAFP recommends that clinicians counsel, encourage, and facilitate planned vaginal birth after cesarean so that women can make informed decisions," the authors write. "The AAFP strongly recommends that clinicians inform women who have had a prior vaginal birth that they have a high likelihood of vaginal birth after cesarean. Unless there are specific contraindications to a vaginal birth, these women should be encouraged to plan LAC/VBAC and should be offered referral to clinicians and facilities capable of providing this service if not available locally."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths